Oliver Lagore Vanvalin Investment Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $10.8K | Sell |
260
-504
| -66% | -$21K | ﹤0.01% | 431 |
|
|
2024
Q3 | $51.1K | Sell |
764
-350
| -31% | -$23.4K | 0.01% | 246 |
|
|
2024
Q2 | $132K | Sell |
1,114
-476
| -30% | -$56.5K | 0.04% | 145 |
|
|
2024
Q1 | $169K | Buy |
1,590
+1,477
| +1,307% | +$157K | 0.05% | 134 |
|
|
2023
Q4 | $11.2K | Hold |
113
| – | – | ﹤0.01% | 391 |
|
|
2023
Q3 | $11.7K | Hold |
113
| – | – | ﹤0.01% | 411 |
|
|
2023
Q2 | $13.7K | Hold |
113
| – | – | 0.01% | 412 |
|
|
2023
Q1 | $17.4K | Hold |
113
| – | – | 0.01% | 301 |
|
|
2022
Q4 | $20.3K | Sell |
113
-10
| -8% | -$1.8K | 0.01% | 270 |
|
|
2022
Q3 | $15K | Hold |
123
| – | – | 0.01% | 279 |
|
|
2022
Q2 | $18K | Sell |
123
-50
| -29% | -$7.32K | 0.01% | 268 |
|
|
2022
Q1 | $30K | Buy |
+173
| New | +$30K | 0.02% | 215 |
|